RBA Wealth Management’s CVS Health CVS Stock Holding History

RBA Wealth Management’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-54,407	Closed	-$3.21M	–	90
2024 Q2	$3.21M	Buy	54,407 +1,592	+3%	+$99.6K	1.29%	41
2024 Q1	$4.21M	Buy	52,815 +1,539	+3%	+$118K	1.71%	30
2023 Q4	$4.05M	Buy	51,276 +915	+2%	+$65.1K	1.77%	31
2023 Q3	$3.52M	Buy	50,361 +1,789	+4%	+$127K	1.69%	30
2023 Q2	$3.36M	Buy	48,572 +1,192	+3%	+$84.8K	1.57%	34
2023 Q1	$3.52M	Buy	47,380 +1,438	+3%	+$121K	1.75%	31
2022 Q4	$4.28M	Buy	45,942 +705	+2%	+$68K	2.25%	13
2022 Q3	$4.31M	Buy	45,237 +564	+1%	+$55.8K	2.48%	7
2022 Q2	$4.14M	Buy	44,673 +452	+1%	+$44.1K	2.29%	12
2022 Q1	$4.48M	Buy	44,221 +905	+2%	+$95.1K	2.15%	11
2021 Q4	$4.47M	Buy	+43,316	New	+$4M	2.11%	10
2021 Q2	–	Sell	-42,052	Closed	-$3.16M	–	81
2021 Q1	$3.16M	Buy	42,052 +886	+2%	+$64.5K	2.68%	12
2020 Q4	$2.81M	Buy	41,166 +368	+0.9%	+$23.9K	1.69%	22
2020 Q3	$2.38M	Buy	40,798 +1,845	+5%	+$115K	1.61%	23
2020 Q2	$2.53M	Buy	38,953 +2,189	+6%	+$138K	1.84%	18
2020 Q1	$2.18M	Buy	36,764 +2,753	+8%	+$184K	1.89%	17
2019 Q4	$2.52M	Buy	34,011 +1,216	+4%	+$85.4K	1.72%	27
2019 Q3	$2.07M	Buy	32,795 +2,470	+8%	+$146K	1.58%	33
2019 Q2	$1.65M	Buy	30,325 +2,154	+8%	+$116K	1.28%	42
2019 Q1	$1.52M	Buy	+28,171	New	+$1.74M	1.18%	41

Other funds holding CVS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

RBA Wealth Management's CVS Position: Q3 2024 in Review

RBA Wealth Management sold out of CVS Health (CVS) in Q3 2024, closing a stake of 54,407 shares — an estimated $3.21M sold.

RBA Wealth Management first reported a position in CVS in Q1 2019 and held it in 20 quarters. The position peaked at $4.48M in Q1 2022. 1,841 funds tracked by Wall St. Rank hold CVS as of Q3 2024.

RBA Wealth Management reported no remaining CVS Health position as of Q3 2024 after selling out during the quarter.
RBA Wealth Management sold 54,407 CVS Health shares in Q3 2024, an estimated $3.21M.
RBA Wealth Management first reported a position in CVS Health in Q1 2019 and held it in 20 quarters.
RBA Wealth Management's CVS Health position peaked at $4.48M in Q1 2022.
1,841 funds tracked by Wall St. Rank held CVS Health as of Q3 2024.

Based on RBA Wealth Management's 13F filing for Q3 2024, filed 21 Oct 2024.